Site Map

• About IHMF Activities
  
• Welcome to the IHMF
  
• 11th Annual Meeting of the IHMF
  
• 10th Annual Meeting of the IHMF
  
• About the Monographs/Guidelines
  
• Monographs
  
• Management Guidelines
  
• Posters
  
• About the Journal
  
• Current issue
  
• Herpes journal supplements
  
• Previous issues
  
• About the Learning Zone
  
• Diagnostic Atlas
  
• Slide Lectures
  
• About Regional Management Forums
  
• North America
  
• South America
  
• Europe
  
• Africa
  
• Middle East
  
• Asia
  
• Australasia/Oceania
  
• About Physicians' Resources
  
• Herpesviruses
  
• Primary Care Toolkits
  
• Patient Information Leaflets
  
• IHMF meeting presentations
  
• IHMF meeting abstracts
  
• Key papers
  
• Forthcoming meetings
  
• External links
  
• Diagnosis
  
  • Amniocentesis
    
  • Antigen (direct) detection
    
  • Asymptomatic (subclinical) infection
    
  • Atypical manifestations
    
  • Culture
    
  • ELISA
    
  • Lesions (vesicles, papules)
    
  • Physical examination
    
  • Polymerase chain reaction (PCR)
    
  • pp65 antigenaemia
    
  • Prenatal diagnosis
    
  • Sensitivity, specificity
    
  • Serology/serological (indirect) tests and screening
    
  • Signs & symptoms
    
  • Swab
    
  • Transmission
    
  • Unrecognized infection
    
  • Western blot
    
• Disease (A-G)
  
  • Atherosclerosis
    
  • Body cavity-based lymphoma
    
  • Burkitt's lymphoma
    
  • Castleman's disease
    
  • CMV disease (syndrome)
    
  • CMV pneumonitis
    
  • CMV retinitis
    
  • Co-factors
    
  • Congenital (CMV, VSV, HSV) infection
    
  • Duncan's syndrome
    
  • Eczema herpeticum
    
  • Encephalitis
    
  • Erythema multiforme
    
  • Exanthem subitum
    
  • Facial herpes (orolabial herpes, coldsore)
    
  • Genital herpes
    
  • Gingivostomatitis
    
• Disease (H-Z)
  
  • Herpes zoster ophthalmicus
    
  • Herpes zoster (shingles)
    
  • Herpetic whitlow
    
  • Hodgkin's disease
    
  • Indirect effects of CMV infection
    
  • Infectious mononucleosis
    
  • Kaposi's sarcoma
    
  • Maternal (CMV, HSV, VZV) infection
    
  • Multiple sclerosis
    
  • Nasopharyngeal carcinoma
    
  • Neonatal herpes
    
  • Ocular HSV disease
    
  • Postherpetic neuralgia (zoster-associated pain)
    
  • Sensorineural hearing loss
    
  • Varicella (chickenpox)
    
• Drugs and interventions (A-F)
  
  • Aciclovir (oral, intravenous)
    
  • Adoptive immunotherapy
    
  • Caesarean section
    
  • Cidofovir
    
  • Condoms
    
  • (Cortico) steroids
    
  • Counselling
    
  • Drug resistance
    
  • Episodic therapy
    
  • Famciclovir
    
  • Foscarnet
    
• Drugs and interventions (G-Z)
  
  • Ganciclovir
    
  • Immunoglobin (CMVIG, VZIG)
    
  • Penciclovir
    
  • Pre-emptive therapy
    
  • Pre- & post-exposure prophylaxis
    
  • Prodromal therapy
    
  • Suppressive therapy
    
  • Treatment
    
  • Vaccine (vaccination)
    
  • Valaciclovir
    
• Epidemiology
  
  • Acquisition
    
  • Incidence
    
  • Prevalence
    
  • Psychosocial impact
    
  • Public health
    
  • Risk factors
    
  • Seroprevalence
    
  • Shedding - asymptomatic (subclinical)
    
  • Shedding - symptomatic
    
  • Socioeconomic cost
    
  • Transmission - horizontal
    
  • Transmission - vertical
    
• Patient type
  
  • Adolescent(s)
    
  • AIDS
    
  • Bone marrow transplant (BMT)
    
  • Children (child)
    
  • Elderly
    
  • Fetus
    
  • HIV
    
  • Immunocompetent
    
  • Immunocomprised
    
  • Immunosuppressed
    
  • Neonate
    
  • Pregnancy (pregnant)
    
  • Solid organ transplant (liver, heart, kidney, lung)
    
  • Stem cell transplant
    
• Virus
  
  • Alpha herpesvirus(es)
    
  • Beta herpesvirus(es)
    
  • CMV
    
  • EBV
    
  • Gamma herpesvirus(es)
    
  • HHV-6
    
  • HHV-7
    
  • HHV-8 (KSHV)
    
  • HSV
    
  • HSV-1
    
  • HSV-2
    
  • VZV
    

- - - © 1998-2004 Cambridge Medical Publications. All rights reserved.